Efficacy of Roflumilast in Bronchiectasis Patients with Frequent Exacerbations: A Double-Blinded, Randomized, Placebo-Controlled Pilot Clinical Trial
Siwasak Juthong, Pattaraporn Panyarath
Tuberc Respir Dis. 2022;85(1):67-73.   Published online 2021 Aug 3     DOI: https://doi.org/10.4046/trd.2021.0051
Citations to this article as recorded by Crossref logo
Challenges in treating patients with comorbid asthma and bronchiectasis
Mario Cazzola, Luigino Calzetta, Maria Gabriella Matera, Paola Rogliani, Vincenzo Patella
Respiratory Medicine.2025; 238: 107957.     CrossRef
Management erwachsener Patientinnen und Patienten mit Bronchiektasen-Erkrankung
Felix C. Ringshausen, Ingo Baumann, Andrés de Roux, Sabine Dettmer, Roland Diel, Monika Eichinger, Santiago Ewig, Holger Flick, Leif Hanitsch, Thomas Hillmann, Rembert Koczulla, Michael Köhler, Assen Koitschev, Christian Kugler, Thomas Nüßlein, Sebastian
Pneumologie.2024; 78(11): 833.     CrossRef
The role of precision medicine in bronchiectasis: emerging data and clinical implications
Grace Oscullo, David de la Rosa, Marta Garcia Clemente, Rosa Giron, Rafael Golpe, Luis Máiz, Miguel Angel Martinez-Garcia
Expert Review of Respiratory Medicine.2023; 17(4): 279.     CrossRef
Exacerbation Prevention and Management of Bronchiectasis
Joon Young Choi
Tuberculosis and Respiratory Diseases.2023; 86(3): 183.     CrossRef
Bronchiectasis
Miguel Barbosa, James D. Chalmers
La Presse Médicale.2023; 52(3): 104174.     CrossRef
Can Phosphodiesterase 4 Inhibitor Therapy Be Used in Respiratory Diseases Other Than Chronic Obstructive Pulmonary Disease?
Mastiyage R Goonathilake, Sara Waqar, Sheeba George, Wilford Jean-Baptiste, Amina Yusuf Ali, Bithaiah Inyang, Feeba Sam Koshy, Kitty George, Prakar Poudel, Roopa Chalasani, Lubna Mohammed
Cureus.2022;[Epub]     CrossRef